Maxim Group reiterated their hold rating on shares of Virpax Pharmaceuticals (NASDAQ:VRPX – Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. Virpax Pharmaceuticals Price Performance Shares of VRPX opened at $0.72 on Wednesday. The business’s 50 day simple moving average is $2.96 and its 200-day simple moving average is […]